Carson Wealth (CWM LLC)
ITCI

Carson Wealth (CWM LLC)’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,812
Closed -$2.22M – 5384
2025
Q1 		$2.22M Buy
16,812
+2,635
+19% +$328K 0.01% 790
2024
Q4 		$1.18M Buy
14,177
+903
+7% +$74.2K ﹤0.01% 999
2024
Q3 		$971K Buy
13,274
+11,902
+867% +$895K ﹤0.01% 1050
2024
Q2 		$94K Buy
1,372
+626
+84% +$43.4K ﹤0.01% 2010
2024
Q1 		$52K Buy
746
+366
+96% +$25.2K ﹤0.01% 2282
2023
Q4 		$27K Buy
380
+102
+37% +$5.87K ﹤0.01% 2584
2023
Q3 		$14K Sell
278
-64
-19% -$3.73K ﹤0.01% 2951
2023
Q2 		$22K Buy
342
+82
+32% +$5.11K ﹤0.01% 2588
2023
Q1 		$14K Buy
260
+110
+73% +$5.32K ﹤0.01% 2771
2022
Q4 		$8K Buy
150
+46
+44% +$2.31K ﹤0.01% 2966
2022
Q3 		$5K Buy
104
+23
+28% +$1.2K ﹤0.01% 3116
2022
Q2 		$5K Buy
81
+1
+1% +$57 ﹤0.01% 3026
2022
Q1 		$5K Buy
80
+75
+1,500% +$3.9K ﹤0.01% 2887
2021
Q4 		$0 Buy
+5
New +$210 ﹤0.01% 3674

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ITCI Position: Q2 2025 in Review

Carson Wealth (CWM LLC) sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 16,812 shares — an estimated $2.22M sold.

Carson Wealth (CWM LLC) first reported a position in ITCI in Q4 2021 and held it in 14 quarters. The position peaked at $2.22M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Carson Wealth (CWM LLC) reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 16,812 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $2.22M.
  • Carson Wealth (CWM LLC) first reported a position in Intra-Cellular Therapies Inc. in Q4 2021 and held it in 14 quarters.
  • Carson Wealth (CWM LLC)'s Intra-Cellular Therapies Inc. position peaked at $2.22M in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2025, filed 25 Jul 2025.